Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges DOI Open Access
Lei Xu, Yuan Cao,

XU Ya

et al.

Macromolecular Bioscience, Journal Year: 2023, Volume and Issue: 24(3)

Published: Aug. 13, 2023

Abstract Cancer development and progression of cancer are closely associated with the activation oncogenes loss tumor suppressor genes. Nucleic acid drugs (e.g., siRNA, mRNA, DNA) widely used for therapy due to their specific ability regulate expression any cancer‐associated However, nucleic negatively charged biomacromolecules that susceptible serum nucleases cannot cross cell membrane. Therefore, delivery tools required facilitate intracellular drugs. In past few decades, a variety nanoparticles (NPs) designed developed therapy. particular, polymeric NPs in response abnormal redox status cells have garnered much more attention as potential redox‐triggered nanostructure dissociation rapid release this review, important genes or signaling pathways regulating briefly introduced recent redox‐responsive is systemically summarized. The future NPs‐mediated challenges clinical translation also discussed.

Language: Английский

Role of Nanotechnology in Ischemic Stroke: Advancements in Targeted Therapies and Diagnostics for Enhanced Clinical Outcomes DOI Creative Commons
Virendra Kumar Yadav,

Rachna Gupta,

Abdullah Assiri

et al.

Journal of Functional Biomaterials, Journal Year: 2025, Volume and Issue: 16(1), P. 8 - 8

Published: Jan. 1, 2025

Each year, the number of cases strokes and deaths due to this is increasing around world. This could be work stress, lifestyles, unhealthy food habits, several other reasons. Currently, there are traditional methods like thrombolysis mechanical thrombectomy for managing strokes. The current approach has limitations, delayed diagnosis, limited therapeutic delivery, risks secondary injuries. So, a need some effective reliable management strokes, which help in early diagnosis followed by treatment Nanotechnology played an immense role recently, it emerged as transformative solution offering innovative diagnostic tools strategies. Nanoparticles (NPs) belonging classes, including metallic (metallic metal oxide), organic (lipids, liposome), carbon, can cross blood–brain barrier may exhibit potential various Moreover, these NPs have exhibited promise improving imaging specificity delivery precise drug real-time monitoring efficacy. Nanomaterials cerium oxide (CeO2) liposome-encapsulated agents neuroprotective properties that reduce oxidative stress promote neuroregeneration. In present article, authors emphasized significant advancements nanomedicine stroke, NPs-based systems, neuroregenerative therapies, multimodal advancements.

Language: Английский

Citations

1

Inflammation-targeting nanoparticles impede neutrophil infiltration and scavenge ROS for acute lung injury alleviation DOI
Ling Ma, Fang Chen, Shuang Chen

et al.

International Journal of Pharmaceutics, Journal Year: 2025, Volume and Issue: 673, P. 125359 - 125359

Published: Feb. 13, 2025

Language: Английский

Citations

1

In vivo self-assembled shape-memory polyurethane for minimally invasive delivery and therapy DOI
Shifen Li, Hua Zhang,

Jieqi Xie

et al.

Materials Horizons, Journal Year: 2023, Volume and Issue: 10(9), P. 3438 - 3449

Published: Jan. 1, 2023

Advanced elastomers are highly demanded for the fabrication of medical devices minimally invasive surgery (MIS). A diselenide-containing, shape-memory and self-healing polyurethane MIS is illustrated in myocardial infarction therapy.

Language: Английский

Citations

19

The mitochondria-targeted Kaempferol nanoparticle ameliorates severe acute pancreatitis DOI Creative Commons
E Wen, Yi Cao,

Shiwen He

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: April 3, 2024

Abstract Kaempferol (KA), an natural antioxidant of traditional Chinese medicine (TCM), is extensively used as the primary treatment for inflammatory digestive diseases with impaired redox homeostasis. Severe acute pancreatitis (SAP) was exacerbated by mitochondrial dysfunction and abundant ROS, which highlights role antioxidants in targeting function. However, low bioavailability high dosage KA leading to unavoidable side effects limits clinical transformation. The mechanisms poor largely unexplored, hindering development efficient strategies maximizing medicinal KA. Here, we engineered a novel thioketals (TK)-modified based on DSPE-PEG2000 liposomal codelivery system improving avoiding (denotes DSPE-TK-PEG2000-KA, DTM@KA NPs). We demonstrated that liposome exerts profound impacts damaging intracellular homeostasis reducing GSH depletion activating Nrf2, synergizes reinforce inhibition inadequate fission, excessive fusion mitophagy resulting inflammation apoptosis; then, restored strengthens ATP supply PAC renovation Interestingly, TK bond proved main functional structure improve above efficacy compared absence bond. Most importantly, NPs obviously suppresses death negligible vitro vivo. Mechanismly, facilitated STAT6-regulated precursor proteins transport via interacting TOM20 further promote Drp1-dependent fission Pink1/Parkin-regulated enhanced lysosomal degradation removing damaged mitochondria then reduce apoptosis. Generally, synergistically improved homeostasis, energy metabolism response regulating TOM20-STAT6-Drp1 signaling promoting SAP. Consequently, such TCM’s active ingredients-based nanomedicine strategy be expected innovative approach SAP therapy. Graphical

Language: Английский

Citations

8

Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders DOI
Sumel Ashique, Neeraj Mishra, Shubhrajit Mantry

et al.

Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 28, 2024

Language: Английский

Citations

8

Inhaled NIR‐II Nanocatalysts for Real‐Time Monitoring and Immunomodulatory Therapy of Acute Lung Injury DOI
Yi Li, Dongfang Liu, Ting Chen

et al.

Advanced Functional Materials, Journal Year: 2024, Volume and Issue: unknown

Published: May 13, 2024

Abstract Acute lung injury (ALI) poses a significant and escalating medical challenge, where precise diagnosis timely intervention hold utmost importance in halting its deterioration. Nevertheless, persistent obstacles arise from the lack of agents proficient both real‐time efficient mitigation ALI. Here, biocatalytic second near‐infrared (NIR‐II) fluorescence‐illuminating nanoplatform is designed to simultaneously facilitate monitoring robust inflammation alleviation The study first develops new aggregation‐induced emission luminogen with trifluoromethyl substitutions, which increase NIR‐II wavelength fluorescence brightness. molecular probe further integrated into hollow ceria nanostructures, cloaked pre‐activated macrophage membranes for targeted intervention. Upon inhalation administration ALI mice, theranostic nanoagents leverage bright active inflammation‐tropic properties vivo sensitive imaging ALI, also facilitates tracking nanoagents’ distribution dynamic fate within pneumonia milieu. Concurrently, catalytic prowess nanoplatforms efficaciously scavenges excess reactive oxygen species, dampens proinflammatory cytokines, promotes repolarization, substantially alleviating acute damage. multifaceted integrates bioimaging nanocatalysis‐mediated immunoregulation, offering versatile promising approach addressing intricate challenges posed by diseases.

Language: Английский

Citations

7

S1PR3 inhibition protects against LPS-induced ARDS by inhibiting NF-κB and improving mitochondrial oxidative phosphorylation DOI Creative Commons
Junnan Peng, Rui Tang, Jing He

et al.

Journal of Translational Medicine, Journal Year: 2024, Volume and Issue: 22(1)

Published: June 5, 2024

Abstract Background Inflammation and endothelial barrier dysfunction are the major pathophysiological changes in acute respiratory distress syndrome (ARDS). Sphingosine-1-phosphate receptor 3 (S1PR3), a G protein-coupled receptor, has been found to mediate inflammation cell (EC) integrity. However, function of S1PR3 ARDS not fully elucidated. Methods We used murine lipopolysaccharide (LPS)-induced model an LPS- stimulated ECs investigate role anti-inflammatory effects protection during ARDS. Results that expression was increased lung tissues mice with LPS-induced TY-52156, selective inhibitor, effectively attenuated by suppressing proinflammatory cytokines restored repairing adherens junctions reducing vascular leakage. inhibition achieved adeno-associated virus vivo small interfering RNA vitro. Both vitro studies demonstrated pharmacological or genetic protected against inhibiting NF-κB pathway improving mitochondrial oxidative phosphorylation. Conclusions protects via suppression pulmonary promotion phosphorylation, indicating is potential therapeutic target for

Language: Английский

Citations

7

Recent advances in reactive oxygen species (ROS)-responsive drug delivery systems for photodynamic therapy of cancer DOI Creative Commons
Danrong Hu, Yicong Li, Ran Li

et al.

Acta Pharmaceutica Sinica B, Journal Year: 2024, Volume and Issue: 14(12), P. 5106 - 5131

Published: Nov. 2, 2024

Reactive oxygen species (ROS)-responsive drug delivery systems (DDSs) have garnered significant attention in cancer research because of their potential for precise spatiotemporal release tailored to high ROS levels within tumors. Despite the challenges posed by distribution heterogeneity and endogenous supply constraints, this review highlights strategic alliance ROS-responsive DDSs with photodynamic therapy (PDT), enabling selective leveraging PDT-induced enhanced therapeutic efficacy. This delves into biological importance progression treatment. We elucidate detail operational mechanisms linkers, including thioether, thioketal, selenide, diselencide, telluride aryl boronic acids/esters, as well latest developments nanomedicines that integrate PDT strategies. These insights are intended inspire design innovative nanocarriers PDT.

Language: Английский

Citations

6

COVID-19 inflammation and implications in drug delivery DOI
Makhloufi Zoulikha, Feifei Huang, Zhenfeng Wu

et al.

Journal of Controlled Release, Journal Year: 2022, Volume and Issue: 346, P. 260 - 274

Published: April 27, 2022

Language: Английский

Citations

24

Stimuli-responsive and biomimetic delivery systems for sepsis and related complications DOI
Eman Abdel Rahman Ismail, Nikita Devnarain, Thirumala Govender

et al.

Journal of Controlled Release, Journal Year: 2022, Volume and Issue: 352, P. 1048 - 1070

Published: Nov. 17, 2022

Language: Английский

Citations

23